microdosing semaglutide dose DEXA Scan Everybody’s MICRODOSING Semaglutide and Tirzepatide!

However, this is controversial and not fully conclusive

Ohio Medicaid still does not cover GLP-1 medications for weight loss alone only for Type 2 diabetes (and, since April 2026, narrow Wegovy criteria for cardiovascular risk reduction and MASH)

Research shows that weight loss and improved metabolic health can boost confidence, self-image and sexual self-esteem, which for many patients enhances rather than diminishes desire. Dix noted that because GLPs affect the reward areas of the brain, they are believed to reduce compulsive behaviours

Semaglutide acts on one receptor route, tirzepatide on two and Retatrutide on three (GLP-1, GIP and glucagon)